Comparative Studies on the Human Serum Albumin Binding of the Investigational EGFR Inhibitor KP2187, Its Hypoxia-Activated Cobalt Complex, and a Series of Clinically Approved Inhibitors †
Excerpt
Binding interactions between human serum albumin and four clinically approved epidermal [...]
Share and Cite
Enyedy, E.A.; Dömötör, O.; Borics, A.; Keppler, B.K.; Kowol, C.R. Comparative Studies on the Human Serum Albumin Binding of the Investigational EGFR Inhibitor KP2187, Its Hypoxia-Activated Cobalt Complex, and a Series of Clinically Approved Inhibitors. Proceedings 2019, 22, 27. https://doi.org/10.3390/proceedings2019022027
Enyedy EA, Dömötör O, Borics A, Keppler BK, Kowol CR. Comparative Studies on the Human Serum Albumin Binding of the Investigational EGFR Inhibitor KP2187, Its Hypoxia-Activated Cobalt Complex, and a Series of Clinically Approved Inhibitors. Proceedings. 2019; 22(1):27. https://doi.org/10.3390/proceedings2019022027
Chicago/Turabian StyleEnyedy, Eva Anna, Orsolya Dömötör, Attila Borics, Bernhard K. Keppler, and Christian R. Kowol. 2019. "Comparative Studies on the Human Serum Albumin Binding of the Investigational EGFR Inhibitor KP2187, Its Hypoxia-Activated Cobalt Complex, and a Series of Clinically Approved Inhibitors" Proceedings 22, no. 1: 27. https://doi.org/10.3390/proceedings2019022027